StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Teva Pharma (TEVA) Cut to Junk by S&P; to BB/Stable from BBB-/Watch
February 8, 2018 5:28 PM
Teva Pharma (NYSE:
TEVA
) Cut to Junk at S&P; to BB/Stable from BBB-/Watch
Categories
Corporate News
Credit Ratings
Next Articles
Teva Pharma (TEVA) PT Lowered to $23 at Goldman Sachs; Remains Bullish as Expectations Reset
February 9, 2018 8:52 AM
Teva Pharma (TEVA) PT Lowered to $16.50 at Wells Fargo
February 9, 2018 8:05 AM